Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 210

1.

Randomized phase III study of erlotinib versus observation in patients with no evidence of disease progression after first-line platin-based chemotherapy for ovarian carcinoma: a European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group, and Gynecologic Cancer Intergroup study.

Vergote IB, Jimeno A, Joly F, Katsaros D, Coens C, Despierre E, Marth C, Hall M, Steer CB, Colombo N, Lesoin A, Casado A, Reinthaller A, Green J, Buck M, Ray-Coquard I, Ferrero A, Favier L, Reed NS, Curé H, Pujade-Lauraine E.

J Clin Oncol. 2014 Feb 1;32(4):320-6. doi: 10.1200/JCO.2013.50.5669. Epub 2013 Dec 23.

PMID:
24366937
[PubMed - indexed for MEDLINE]
2.

Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients - a study of the OVCAD consortium.

Pils D, Bachmayr-Heyda A, Auer K, Svoboda M, Auner V, Hager G, Obermayr E, Reiner A, Reinthaller A, Speiser P, Braicu I, Sehouli J, Lambrechts S, Vergote I, Mahner S, Berger A, Cacsire Castillo-Tong D, Zeillinger R.

Eur J Cancer. 2014 Jan;50(1):99-110. doi: 10.1016/j.ejca.2013.09.011. Epub 2013 Oct 28.

PMID:
24176298
[PubMed - indexed for MEDLINE]
3.

The value of serum albumin as a novel independent marker for prognosis in patients with endometrial cancer.

Seebacher V, Grimm C, Reinthaller A, Heinze G, Tempfer C, Hefler L, Polterauer S.

Eur J Obstet Gynecol Reprod Biol. 2013 Nov;171(1):101-6. doi: 10.1016/j.ejogrb.2013.07.044. Epub 2013 Aug 11.

PMID:
24011381
[PubMed - indexed for MEDLINE]
4.

Association of gamma-glutamyltransferase with severity of disease at diagnosis and prognosis of ovarian cancer.

Grimm C, Hofstetter G, Aust S, Mutz-Dehbalaie I, Bruch M, Heinze G, Rahhal-Schupp J, Reinthaller A, Concin N, Polterauer S.

Br J Cancer. 2013 Aug 6;109(3):610-4. doi: 10.1038/bjc.2013.323. Epub 2013 Jul 16.

PMID:
23921280
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Association of myeloperoxidase with ovarian cancer.

Castillo-Tong DC, Pils D, Heinze G, Braicu I, Sehouli J, Reinthaller A, Schuster E, Wolf A, Watrowski R, Maki RA, Zeillinger R, Reynolds WF.

Tumour Biol. 2014 Jan;35(1):141-8. doi: 10.1007/s13277-013-1017-3. Epub 2013 Jul 27.

PMID:
23893381
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation.

Zeimet AG, Reimer D, Huszar M, Winterhoff B, Puistola U, Azim SA, Müller-Holzner E, Ben-Arie A, van Kempen LC, Petru E, Jahn S, Geels YP, Massuger LF, Amant F, Polterauer S, Lappi-Blanco E, Bulten J, Meuter A, Tanouye S, Oppelt P, Stroh-Weigert M, Reinthaller A, Mariani A, Hackl W, Netzer M, Schirmer U, Vergote I, Altevogt P, Marth C, Fogel M.

J Natl Cancer Inst. 2013 Aug 7;105(15):1142-50. doi: 10.1093/jnci/djt144. Epub 2013 Jun 18. Erratum in: J Natl Cancer Inst. 2013 Nov 20;105(22):1763.

PMID:
23781004
[PubMed - indexed for MEDLINE]
Free Article
7.

Does thyroid-stimulating hormone influence the prognosis of patients with endometrial cancer? A multicentre trial.

Seebacher V, Hofstetter G, Polterauer S, Reinthaller A, Grimm C, Schwameis R, Taucher S, Wagener A, Marth C, Concin N.

Br J Cancer. 2013 Jul 9;109(1):215-8. doi: 10.1038/bjc.2013.282. Epub 2013 Jun 13.

PMID:
23764750
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

The strong prognostic value of KELIM, a model-based parameter from CA 125 kinetics in ovarian cancer: data from CALYPSO trial (a GINECO-GCIG study).

You B, Colomban O, Heywood M, Lee C, Davy M, Reed N, Pignata S, Varsellona N, Emons G, Rehman K, Steffensen KD, Reinthaller A, Pujade-Lauraine E, Oza A.

Gynecol Oncol. 2013 Aug;130(2):289-94. doi: 10.1016/j.ygyno.2013.05.013. Epub 2013 May 18.

PMID:
23694718
[PubMed - indexed for MEDLINE]
9.

Impact of conization type on the resected cone volume: results of a retrospective multi-center study.

Grimm C, Brammen L, Sliutz G, Weigert M, Sevelda P, Pils S, Reinthaller A, Polterauer S.

Arch Gynecol Obstet. 2013 Nov;288(5):1081-6. doi: 10.1007/s00404-013-2873-1. Epub 2013 May 7.

PMID:
23649464
[PubMed - indexed for MEDLINE]
10.

The prognostic value of estrogen receptor beta and proline-, glutamic acid- and leucine-rich protein 1 (PELP1) expression in ovarian cancer.

Aust S, Horak P, Pils D, Pils S, Grimm C, Horvat R, Tong D, Schmid B, Speiser P, Reinthaller A, Polterauer S.

BMC Cancer. 2013 Mar 14;13:115. doi: 10.1186/1471-2407-13-115.

PMID:
23497172
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Expression of Bcl-2 and the antiapoptotic BAG family proteins in ovarian cancer.

Aust S, Pils S, Polterauer S, Horvat R, Cacsire Castillo-Tong D, Pils D, Dudek G, Schmid B, Speiser P, Reinthaller A, Grimm C.

Appl Immunohistochem Mol Morphol. 2013 Dec;21(6):518-24. doi: 10.1097/PAI.0b013e318284a053.

PMID:
23455184
[PubMed - indexed for MEDLINE]
12.

Treatment of cervical intraepithelial neoplasia with topical imiquimod: a randomized controlled trial.

Grimm C, Polterauer S, Natter C, Rahhal J, Hefler L, Tempfer CB, Heinze G, Stary G, Reinthaller A, Speiser P.

Obstet Gynecol. 2012 Jul;120(1):152-9. doi: 10.1097/AOG.0b013e31825bc6e8.

PMID:
22914404
[PubMed - indexed for MEDLINE]
13.

Nomogram prediction for overall survival of patients diagnosed with cervical cancer.

Polterauer S, Grimm C, Hofstetter G, Concin N, Natter C, Sturdza A, Pötter R, Marth C, Reinthaller A, Heinze G.

Br J Cancer. 2012 Sep 4;107(6):918-24. doi: 10.1038/bjc.2012.340. Epub 2012 Aug 7.

PMID:
22871885
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Austrian Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO) guideline for prophylaxis with granulocyte colony-stimulating factors (G-CSF) in gynecologic malignancies, including breast cancer.

Petru E, Zeimet AG, Sevelda P, Seifert M, Singer C, Hubalek M, Angleitner-Boubenizek L, Speiser P, Benedicic C, Stummvoll W, Reinthaller A; Austrian Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO).

Wien Klin Wochenschr. 2012 Jun;124(11-12):412-8. doi: 10.1007/s00508-012-0185-2. Epub 2012 Jun 28. Erratum in: Wien Klin Wochenschr. 2012 Sep;124(17-18):669. Singer, Christian [added].

PMID:
22739650
[PubMed - indexed for MEDLINE]
15.

Prognostic value of lymph node ratio and clinicopathologic parameters in patients diagnosed with stage IIIC endometrial cancer.

Polterauer S, Khalil S, Zivanovic O, Abu-Rustum NR, Hofstetter G, Concin N, Grimm C, Reinthaller A, Barakat RR, Leitao MM Jr.

Obstet Gynecol. 2012 Jun;119(6):1210-8. doi: 10.1097/AOG.0b013e318255060c.

PMID:
22617586
[PubMed - indexed for MEDLINE]
16.

External validation of a nomogram predicting overall survival of patients diagnosed with endometrial cancer.

Polterauer S, Zhou Q, Grimm C, Seebacher V, Reinthaller A, Hofstetter G, Concin N, Leitao MM Jr, Barakat RR, Abu-Rustum NR, Iasonos A.

Gynecol Oncol. 2012 Jun;125(3):526-30. doi: 10.1016/j.ygyno.2012.03.030. Epub 2012 Mar 23.

PMID:
22449735
[PubMed - indexed for MEDLINE]
17.

A novel training model for the loop electrosurgical excision procedure: an innovative replica helped workshop participants improve their LEEP.

Hefler L, Grimm C, Kueronya V, Tempfer C, Reinthaller A, Polterauer S.

Am J Obstet Gynecol. 2012 Jun;206(6):535.e1-4. doi: 10.1016/j.ajog.2012.01.016. Epub 2012 Jan 13.

PMID:
22360922
[PubMed - indexed for MEDLINE]
18.

Prognostic significance of gamma-glutamyltransferase in patients with endometrial cancer: a multi-centre trial.

Seebacher V, Polterauer S, Grimm C, Rahhal J, Hofstetter G, Bauer EM, Husslein H, Leipold H, Marth C, Reinthaller A, Concin N.

Br J Cancer. 2012 Apr 24;106(9):1551-5. doi: 10.1038/bjc.2012.16. Epub 2012 Feb 7.

PMID:
22315051
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

The impact of plasma fibrinogen levels on patients with vulvar cancer.

Seebacher V, Polterauer S, Grimm C, Tempfer C, Hefler-Frischmuth K, Reinthaller A, Hefler L.

Eur J Obstet Gynecol Reprod Biol. 2012 Mar;161(1):88-91. doi: 10.1016/j.ejogrb.2011.11.030. Epub 2012 Feb 4.

PMID:
22310943
[PubMed - indexed for MEDLINE]
20.

Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial.

Gladieff L, Ferrero A, De Rauglaudre G, Brown C, Vasey P, Reinthaller A, Pujade-Lauraine E, Reed N, Lorusso D, Siena S, Helland H, Elit L, Mahner S.

Ann Oncol. 2012 May;23(5):1185-9. doi: 10.1093/annonc/mdr441. Epub 2011 Oct 5.

PMID:
21976386
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk